Latest papers

[A drug seeks its disease].

Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation.

Asymmetric conjugate reductions of coumarins. A new route to tolterodine and related coumarin derivatives.

[Follow-up at 24 months after treatment of overactive bladder with 0.2 % sodium chondroitin sulfate].

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.

Tolterodine extended-release for overactive bladder

Ratiometric Ca⁺² measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer

The composition of the essential oil from Cyperus distans rhizome.

An improved primary human nasal cell culture for the simultaneous determination of transepithelial transport and ciliary beat frequency.

Fenton degradation of 4,6-dinitro-o-cresol with Fe(2+)-substituted ion-exchange resin.

Self-collected urine sampling to study the kinetics of urinary toluene (and o-cresol) and define the best sampling time for biomonitoring.

Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study

The pharmacokinetic profile of fesoterodine: similarities and differences to tolterodine.

In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.

Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.

A simple RP-HPLC method for the simultaneous quantitation of chlorocresol, mometasone furoate, and fusidic acid in creams.

[Multinational clinical trial in Japan and Korea on detrusitol].

Evolution of protein-bound uraemic solutes during predilution haemofiltration.

[Morphological changes in retinal neurons in rats with streptozotocin diabetes and their correction by O-isobornylphenol derivative].

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.